Allison Vagner

Patent Agent
Norton Rose Fulbright US LLP
allison.vagner@nortonrosefulbright.com
Allison
Vagner
Allison Vagner
Los Angeles
Forty-First Floor
555 South Flower Street
Los Angeles, California
90071
United States
+1 213 892 9205

Allison Vagner is a patent agent in Norton Rose Fulbright's Los Angeles office. Allison's practice is focused on domestic and foreign patent preparation and prosecution and related intellectual property issues in support of developing and commercializing technologies from industry, academia and research institutions. She specializes in IP portfolio management, application drafting, US and foreign patent prosecution, development of filing strategies, IP due diligence and preparation of patentability and freedom-to-operate analyses.

She is a registered patent agent with broad technical strength in the physical sciences, with a particular emphasis on technologies related to chemistry, biochemistry, biology, pharmaceuticals, medical devices, materials science, nanotechnology and energy.

Allison's extensive scientific and professional background allows her to work with client teams at all levels, including scientists, technology managers and executives, in order to develop focused and cost-effective strategies for specific patent families and across broader patent portfolios.

Representative experience

  • IP Due Diligence - Represented foreign venture capital firm in US$100m acquisition of technology holding company with a diverse international patent portfolio, with complex litigation history, extensive licensing issues and various ownership complications
  • Pharmaceutical Patent Portfolio Development - Represented early stage pharmaceutical company in developing short term and long term patent filing strategies, including strategic international filings, defensive patent filings and investment filings, including managing the portfolio through corporate restructuring and clinical trials
  • University Technology Commercialization - Represented research institution in establishing an international and comprehensive patent portfolio surrounding technology developed in collaboration with multiple parties (spin out company, partner research institutions and government research agencies), addressing licensing issues and strategically developing the portfolio through multiple funding rounds to maximize value

Education

  • MA, Chemistry, University of Southern California Los Angeles, 2004
  • BS, Chemistry, University of Washington, 2000

Admissions

  • US Patent and Trademark Agent
Bio